Market Analysis

Mass spectrometry growing as tool for tailored drugs and biomarker ID, market analysis shows

Published in Biotech Business Week, December 25th, 2006

Research and Markets has released, "U.S. Life Science Mass Spectrometry Markets," in which Frost & Sullivans expert analysts examine the mass spectrometry market, which is composed of single quadrupole, triple quadrupole, ion trap, MALDI, and high resolution mass spectrometry.

Mass spectrometry is a tool that is growing in use as the market for tailored drugs and the need to identify biomarkers increases. The completion of the human genome project has ushered in a new era of research focused on the protein products encoded by the genome.

This era will be far more complicated to understand, and will require far more powerful instruments that can...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-12-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry